Sort
21,453 grants matching “tuberculosis”
Early Preclinical Testing of TB Drugs in Mice
$93,506Anne J. Lenaerts · Colorado State University · P01 · FY2006 · AI
Cultural Intervention for Latinos with TB Infection
$93,410Georgetown University · R15 · FY2005 · NR
Quinolone Action During Mycobacterial Growth Arrest
$93,318Karl A Drlica · Public Health Research Institute · R21 · FY2006 · AI
NEW MEXICO TUBERCULOSIS ELIMINATION AND LAB COOPERATIVE AGREEMENT
$93,142Diana Fortune · New Mexico State Department Of Health · U52 · FY2016 · PS
High-Throughput TB Vaccine Antigen Discovery
$92,992Amanda Martinot · Tufts University Boston · K08 · FY2018 · AI
Genomic and immunological comparisons of M africanum and M tuberculosis
$92,895Bouke C De Jong · New York University School Of Medicine · K01 · FY2010 · TW
3-Ketoacyl ACP Synthase III: A Novel Antibiotic Target
$92,890Virginia Commonwealth University · R01 · FY2005 · AI
Towards a generalizable drug discovery framework based on intrinsically disordered regions
$92,849Gil Alterovitz · Boston Children'S Hospital · R01 · FY2019 · GM
Structure and Mechanism of Metalloregulatory Proteins
$92,793David P. Giedroc · Texas A&M University · R01 · FY2007 · GM
Shortening Tuberculosis Chemotherapies using N-acetylcysteine
$92,785William Robert Jacobs · Albert Einstein College Of Medicine · R21 · FY2018 · AI
A dual-layer flat panel x-ray detector based on an engineered amorphous chalcogenide alloy for quantifying coronary artery calcium
$92,745Shiva Abbaszadeh · University Of California Santa Cruz · R01 · FY2024 · EB
What Precursors Become Lung-Resident CD4 Memory that Protect Against Respiratory Infections or Cause Lung Pathology?
$92,708Priyadharshini Devarajan · State University New York Stony Brook · R21 · FY2025 · AI
Detecting pathogen and host factors on extracellular vesicles for pediatric TB diagnosis and management
$92,669Tony Y. Hu · Tulane University Of Louisiana · R01 · FY2025 · HD
DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial
$92,645Payam Nahid · University Of California, San Francisco · U01 · FY2025 · AI
Integrating single-cell omics and ancestry-adjusted eQTL mapping to characterize Tuberculosis immune response
$92,591Brenna M Henn · University Of California At Davis · R21 · FY2025 · AI
An Immunomics Approach To Explore Drug-Induced Resistance To Schistosomes
$92,422Rodrigo Correa-Oliveira · Foundation For Research Development · P50 · FY2012 · AI
Fatty Acid Analogs to treat Cancer/Infectious Diseases
$92,250University Of Puerto Rico Rio Piedras · S06 · FY2004 · GM
Toll-like Receptor 2, Vitamin D, and Extrapulmonary Tuberculosis
$92,191Christina A. Fiske · Vanderbilt University · K23 · FY2015 · AI
NK cell IL-10 production during bacterial infections
$92,090Laurel L Lenz · University Of Colorado Denver · R01 · FY2019 · AI
NMR METABOLOMICS CORE FOR REDOX BIOLOGY
$92,089Robert A Powers · University Of Nebraska Lincoln · P20 · FY2010 · RR
RIFAPENDINE/ISONIAZID FOR 3 MONTHS VS 9 MO FOR LATENT TB (STUDY 26) (HIV)
$92,037Marc H Weiner · University Of Texas Hlth Science Center · M01 · FY2007 · RR
Fatty Acid Analogs to treat Cancer/Infectious Diseases
$92,033Nestor Manuel Carballeira · University Of Puerto Rico Rio Piedras · S06 · FY2006 · GM
Central Operations Core
$91,887Sebastian Engel · Georgia Institute Of Technology · U19 · FY2015 · TW
International Research in Thailand
$91,847Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Entry Mechanisms of Mycobacterium marinum
$91,586University Of Nebraska Lincoln · R01 · FY2005 · AI